Long Focus Capital Management’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Hold
829,748
0.01% 96
2025
Q4
$1.09M Hold
829,748
0.03% 90
2025
Q3
$1.17M Hold
829,748
0.04% 91
2025
Q2
$3.71M Hold
829,748
0.14% 78
2025
Q1
$3.79M Buy
829,748
+85,000
+11% +$468K 0.13% 80
2024
Q4
$4.53M Buy
744,748
+421,931
+131% +$2.88M 0.15% 72
2024
Q3
$2.54M Buy
322,817
+42,270
+15% +$426K 0.09% 72
2024
Q2
$3.14M Buy
280,547
+46,647
+20% +$545K 0.12% 71
2024
Q1
$2.96M Hold
233,900
0.15% 69
2023
Q4
$3.21M Buy
233,900
+5,100
+2% +$59.7K 0.11% 68
2023
Q3
$2.58M Buy
228,800
+110,000
+93% +$1.32M 0.09% 69
2023
Q2
$1.59M Buy
118,800
+20,000
+20% +$235K 0.07% 72
2023
Q1
$1.15M Hold
98,800
0.06% 85
2022
Q4
$1.19M Buy
+98,800
New +$1.28M 0.08% 76

Other funds holding BIOX

Long Focus Capital Management's BIOX Position: Q1 2026 in Review

Long Focus Capital Management held its Bioceres Crop Solutions (BIOX) position steady in Q1 2026 at 829,748 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #96.

Long Focus Capital Management first reported a position in BIOX in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.53M in Q4 2024. 32 funds tracked by Wall St. Rank hold BIOX as of Q1 2026.

  • Long Focus Capital Management held 829,748 shares of Bioceres Crop Solutions worth $369K as of Q1 2026.
  • Long Focus Capital Management left its Bioceres Crop Solutions share count unchanged in Q1 2026.
  • Bioceres Crop Solutions made up 0.01% of Long Focus Capital Management's portfolio in Q1 2026, its #96 holding.
  • Long Focus Capital Management first reported a position in Bioceres Crop Solutions in Q4 2022 and has held it in 14 quarters since.
  • Long Focus Capital Management's Bioceres Crop Solutions position peaked at $4.53M in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2026.

Based on Long Focus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.